CMPX Projected Dividend Yield
Compass Therapeutics Inc ( NASDAQ : CMPX )Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Co.'s pipeline includes product candidates that utilize its understanding of the tumor microenvironment, including both angiogenesis-targeted agents and immune-oncology focused agents. These product candidates are designed to support critical components required for an anti-tumor response to cancer. These include modulation of the microvasculature via angiogenesis-targeted agents, and induction of an immune response via activators on effector cells in the tumor microenvironment. 20 YEAR PERFORMANCE RESULTS |
CMPX Dividend History Detail CMPX Dividend News CMPX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |